{"id":812,"date":"2016-09-21T10:32:39","date_gmt":"2016-09-21T08:32:39","guid":{"rendered":"https:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/uncategorized\/md-deutschland-verraet-3-themen-der-keynote\/"},"modified":"2022-07-04T06:59:21","modified_gmt":"2022-07-04T04:59:21","slug":"md-deutschland-verraet-3-themen-der-keynote","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/","title":{"rendered":"MD Germany disclose three topics of NAMUR keynote"},"content":{"rendered":"<p>Andreas Helget, Managing Director of Yokogawa Germany, give insights about NAMUR Annual General Meeting 2016. He says, how Yokogawa Germany is going to extend its business backbone.<\/p>\n<p>Would you like to discover more? Ask your questions. Write a comment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Andreas Helget, Managing Director of Yokogawa Germany, give insights about NAMUR Annual General Meeting 2016. He says, how Yokogawa Germany is going to extend its business backbone. Would you like to discover more? Ask your questions. Write a comment. <\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/\"> <span class=\"screen-reader-text\">MD Germany disclose three topics of NAMUR keynote<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":103,"featured_media":553,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","footnotes":""},"categories":[53,54,56,57],"tags":[],"coauthors":[79],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.13 (Yoast SEO v20.13) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MD Germany disclose three topics of NAMUR keynote - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MD Germany disclose three topics of NAMUR keynote\" \/>\n<meta property=\"og:description\" content=\"Andreas Helget, Managing Director of Yokogawa Germany, give insights about NAMUR Annual General Meeting 2016. He says, how Yokogawa Germany is going to extend its business backbone. Would you like to discover more? Ask your questions. Write a comment.  MD Germany disclose three topics of NAMUR keynote Read More &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-21T08:32:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-04T04:59:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1579\" \/>\n\t<meta property=\"og:image:height\" content=\"887\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Andreas Helget\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/\"},\"author\":{\"name\":\"Andreas Helget\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/c6c15133cc0485c7555f45ee42418525\"},\"headline\":\"MD Germany disclose three topics of NAMUR keynote\",\"datePublished\":\"2016-09-21T08:32:39+00:00\",\"dateModified\":\"2022-07-04T04:59:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/\"},\"wordCount\":46,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\"},\"articleSection\":[\"Automation\",\"Corporate\",\"Optimisation\",\"Services\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/\",\"name\":\"MD Germany disclose three topics of NAMUR keynote - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website\"},\"datePublished\":\"2016-09-21T08:32:39+00:00\",\"dateModified\":\"2022-07-04T04:59:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MD Germany disclose three topics of NAMUR keynote\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Yokogawa&#039;s Chemical &amp; Pharma Blog\",\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/c6c15133cc0485c7555f45ee42418525\",\"name\":\"Andreas Helget\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/image\/d11ce512bca58d005c116bcae861b383\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Helget_9399_250x250-150x150.jpg\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Helget_9399_250x250-150x150.jpg\",\"caption\":\"Andreas Helget\"},\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/helget\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MD Germany disclose three topics of NAMUR keynote - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/","og_locale":"en_US","og_type":"article","og_title":"MD Germany disclose three topics of NAMUR keynote","og_description":"Andreas Helget, Managing Director of Yokogawa Germany, give insights about NAMUR Annual General Meeting 2016. He says, how Yokogawa Germany is going to extend its business backbone. Would you like to discover more? Ask your questions. Write a comment.  MD Germany disclose three topics of NAMUR keynote Read More &raquo;","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2016-09-21T08:32:39+00:00","article_modified_time":"2022-07-04T04:59:21+00:00","og_image":[{"width":1579,"height":887,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png","type":"image\/png"}],"author":"Andreas Helget","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/"},"author":{"name":"Andreas Helget","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/c6c15133cc0485c7555f45ee42418525"},"headline":"MD Germany disclose three topics of NAMUR keynote","datePublished":"2016-09-21T08:32:39+00:00","dateModified":"2022-07-04T04:59:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/"},"wordCount":46,"commentCount":0,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization"},"articleSection":["Automation","Corporate","Optimisation","Services"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/","name":"MD Germany disclose three topics of NAMUR keynote - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website"},"datePublished":"2016-09-21T08:32:39+00:00","dateModified":"2022-07-04T04:59:21+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/md-deutschland-verraet-3-themen-der-keynote\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/"},{"@type":"ListItem","position":2,"name":"MD Germany disclose three topics of NAMUR keynote"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/","name":"Chemical Pharma Blog","description":"Yokogawa&#039;s Chemical &amp; Pharma Blog","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/c6c15133cc0485c7555f45ee42418525","name":"Andreas Helget","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/image\/d11ce512bca58d005c116bcae861b383","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Helget_9399_250x250-150x150.jpg","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Helget_9399_250x250-150x150.jpg","caption":"Andreas Helget"},"url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/helget\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png",1579,887,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-150x150.png",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-300x169.png",300,169,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-768x431.png",768,431,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-1024x575.png",1024,575,true],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-1536x863.png",1536,863,true],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png",1579,887,false],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-356x200.png",356,200,true]},"uagb_author_info":{"display_name":"Andreas Helget","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/helget\/"},"uagb_comment_info":0,"uagb_excerpt":"Andreas Helget, Managing Director of Yokogawa Germany, give insights about NAMUR Annual General Meeting 2016. He says, how Yokogawa Germany is going to extend its business backbone. Would you like to discover more? Ask your questions. Write a comment. MD Germany disclose three topics of NAMUR keynote Read More &raquo;","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/812"}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/users\/103"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/comments?post=812"}],"version-history":[{"count":3,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/812\/revisions"}],"predecessor-version":[{"id":11391,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/812\/revisions\/11391"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/media\/553"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/media?parent=812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/categories?post=812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/tags?post=812"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/coauthors?post=812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}